Zingiber officinale (Ginger) is one of the most spice used worldwide and since antiquity it has been used in traditional medicine to treat different diseases. Although ginger is generally considered safe, there are no more information about the mechanism of its therapeutic action and its nutraceutical value. For these reasons the purpose of this work is to apply in vitro digestion model, as the first step in the study of its bioaccessibility, to understand which is the fate of its bioactive compounds after ingestion. This allow us to characterize which ginger metabolite are stable under gastrointestinal conditions and, thus, available for intestinal absorption. The aim of this study is to provide valuable information to better understand ginger pharmacological activities, paving the way for the definition of suitable dosage and source of food matrices to ensure nutritional efficacy.
Nature is the greatest source of pharmacologically active compounds, providing humankind with a vast arsenal of products with diverse chemical structure and biological activities [1] . Therefore, it is not surprising that in the last three decades half of the approved drugs derived from natural sources [2] .
The majority of these molecules are in clinical use as antibiotics, cancer therapeutics, immunosuppressive agents and they are also commercialized as antivirals, anthelmintics, enzyme inhibitors, polymers, and herbicides [3] . In this scenario, nutraceuticals, or "health food", play an important role. Indeed, a growing number of people is using complementary and alternative medicines, dietary supplements and herbal remedies [4] . Nutraceuticals can be described as food or parts of food that provide medical or health benefits including the prevention and/or treatment of a disease. Nutraceuticals have advantages over the drugs because they are reasonably safe, increase the health beneficial, increase the health value, improve medical condition of human body and, in addition, they are easily available and economically affordable [5] .
Ginger (Zingiber officinale) is well known for its nutraceutical value [6] , which can be ascribed to a variety of bioactive compounds including gingerols, zingiberene and shogaols [7] . Ginger is widely used worldwide as a spice and as a medicine [8] . Since antiquity, it has been used in traditional medicine (Ayurvedic, Chinese, and Unani) to treat different diseases that include rheumatoid arthritis, sprains and muscular aches, nausea, constipation and indigestion, fever, infectious diseases and helminthiasis [9] . The number and the nature of ginger constituents vary depending on the place of origin and whether the rhizomes are fresh or dry [10] . The pungent taste of fresh ginger rhizome is attributed to the presence of gingerols (GNs), a group of volatile phenolic compounds with different chain lengths, which appear to be the primary component of ginger reported in the majority of the health-related scientific studies [11] . Gingerols are thermally labile and are transformed at high temperature to shogaols (SGs) [12] , which confer a pungent and spicy-sweet fragrance [13] . During the preparation of dried ginger, GNs are also rapidly converted to the corresponding SGs, among which 6-SG is the most common dehydration product. In many cases, 6-SG has been reported to have better biological activities than 6-GN [14] . Ginger is used under numerous preparations including fresh, dried, pickled, preserved, crystallized, candied and powdered or ground [15] , and it is generally taken orally. The rhizome, which is the horizontal stem from which the roots grow, is the main portion that is consumed.
Although ginger is generally considered safe [16] , the lack of information about the mechanism of its therapeutic action suggests caution about its use. Indeed, recent studies have emphasized the importance of thorough scientific research in establishing the safety and efficacy of potential therapeutic plant remedies and in defining the risks and benefits of herbal medicine. For these reasons, over the last few years the interest in ginger as valuable preventive or therapeutic agent has increased markedly, and scientific studies focusing on verification of ginger's pharmacological and physiological actions have increased accordingly. In this context, an aspect that should not be underestimated is that the bioactive compounds of ginger extract may exert their physiological actions both in the intestinal lumen as well as upon crossing intestinal epithelia and reaching blood circulation. Therefore, modifications made by the gastrointestinal digestion process, the transport mechanisms across the intestinal epithelium and the enzymatic modifications taking place at these sites, are also important parameters to be considered. Thus, the application of in vitro digestion models is a necessary step to evaluate the stability of bioactive compounds. Numerous studies comparing in vitro and in vivo results often reveals important analogies, because the key enzymes used in vitro experiments (pepsin, chymotrypsin and trypsin) are the same operating in vivo [17] . The purpose of this work is to apply an in vitro physiological digestion model, in order to evaluate the stability of ginger extracts under gastrointestinal conditions. More in details, we aim at understanding which bioactive compounds are stable and available for the intestinal absorption in order to have more information about the fate of ginger metabolites after ingestion.
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Many qualitative and/or quantitative methods have been reported for the analysis of fresh and dried ginger [18] . A variety of solvents such as methanol [19] , ethanol, DCM, acetone, and pressurized CO 2 [20] have been used for ginger extraction. Extraction methods to obtain bioactive compounds from ginger also include, among others, reflux, sonication, and high-pressure Soxhlet extraction [21] . Based on the literature, the most effective method for extracting gingerol compounds might be using methanol as the solvent. In the present study, we do not employ reflux methods for the extraction of ginger because of the transformation of gingerols to shogaols, that occurs at high temperature [22] . After the extraction followed by concentration process the HPLC analysis of each ginger extract was carried out considering 6-gingerol as the internal standard. This allowed the normalization of the data on the variation of 6-gingerol signal, assessing if the different bioactive compounds have different stability under in vitro gastrointestinal digestion. HPLC and Gas Chromatography (GC) have been typically used to analyse gingerols and shogaols in ginger [23] . In the present study, we chose HPLC analysis since the GC method might cause a conversion of 6-gingerol to 6-shogaol through the high temperatures. HPLC chromatograms of the major ginger bioactive compounds are listed in Figure 1 . The gastrointestinal digestion process has a great influence on the metabolites stability. In this context, digestion model simulates the real conditions of the human gastrointestinal tract and represents an adequate method to assess the nutritional value and the biological activity of ginger. Thus, in order to understand the effects of the digestion process, ginger extract samples were subjected to a simulated gastrointestinal digestion. The digestion procedure was 2005), using exactly the same procedure set up by the authors: the method follows the subsequent steps of the digestion process in terms of composition of the juices in the different compartments (simulation of salivary juice, gastric juices, duodenal juice and bile) as well as the relative residence times. We performed an HPLC-ESI-MS analysis of ginger extracts before and after the digestion process. In particular, comparing the profile of the ginger extracts with that of the digesta, no substantial differences were observed. This fact highlights that the metabolites profile of digesta were the same of the extract before digestion. As shown in Figure 2 , all the major metabolites of ginger extract are conserved after the digestion process indicating also that there are no differences about their amount before and after the experiments. This indicates that the major ginger bioactive compounds are stable to the gastrointestinal conditions and once reached the smallintestine they are available to be absorbed.
We have herein reported a preliminary study aimed at determining the bioaccessibility of ginger metabolites. In vitro studies have been developed to simulate the physiologic conditions and the sequence of events that occur during digestion in the human gastrointestinal tract. In this study, as a first step, an in vitro gastrointestinal method is applied to the ginger extract, mimicking the physiochemical conditions that take place during human digestion, considering the 3 areas of the human digestive system (mouth, stomach, and intestine) [24] . The small intestine was taken as an end-point of the experiment to evaluate the stability of ginger metabolites to gastrointestinal digestion, with the possibility of reproducing in vivo the results obtained from in vitro experiments. The second step will be the determination of the amount of nutrient or bioactive compound that is assimilated from the digesta by the intestinal mucosa. Concluding, the evaluation of the bioaccessibility of ginger metabolites represents an important information in order to better understand the pharmacological activities of such components and, in addition, it provides valuable information to select the suitable dosage and source of food matrices to ensure nutritional efficacy of ginger.
Experimental
Plant material: Edible ginger (Zingiber officinale, 1 kg) was purchased in a local supermarket, Parma (Italy), imported from India. The ginger rhizomes were stored at 4°C and washed thoroughly before use. Washed ginger was sliced into small pieces and freezed with liquid nitrogen at -78°C for ∼1 h. Finally, the dried samples were ground with a mortar and pestle prior to solvent extraction. Chemicals: Methanol and Acetonitrile (LC grade) were purchased from J.T. Baker (Mallinckrodt Baker, Phillipsburg, NJ, USA) Formic acid (99%) was obtained from Acros Organics (New Jersey, United States). Ultrapure water was produced in our laboratory utilizing an Alpha-Q system (Millipore, Marlborough, MA, USA). Pepsin from porcine gastric mucosa, trypsin from porcine pancreas, α-chymotrypsin from bovine pancreas, α-amylase from barley malt (type VIIIa), uric acid, mucin from porcine stomach (type III), glucose, glucuronic acid, glucosamine hydrochloride, bovine serum albumin, pancreatin from porcine pancreas, lipase from porcine pancreas (type II), bovine and ovine bile, sodium dihydrogen phosphate, potassium chloride, sodium hydroxide, sodium phosphate dibasic dodecahydrate, monobasic potassium phosphate, acetonitrile, methanol, urea, acetic acid, were all purchased from Sigma-Aldrich (St. Louis, MO, USA). Hydrochloric acid (37% v/v), sodium hydroxide, sodium hydrogen carbonate, calcium chloride, ammonium chloride, potassium thiocyanate, and potassium hydroxide were purchased from Carlo Erba (Milan, Italy). Sodium chloride was purchased from AnalaR Normapur (Milan, Italy). Sodium sulfate was purchased from Riedel de Haen (Seelze, Germany). Magnesium chloride hexahydrate was purchased from Fluka (Sigma-Aldrich, St. Louis, MO, USA).
Sample preparation: Ginger roots were crumbled in a mortar by using liquid nitrogen and then stored at -20°C until extraction. Gingerols and shogaols were extracted by stirring 5 g of finely ground matrix with 20 mL of methanol for 12 hours at room temperature. The extract was then filtered on a paper filter and 500 µL were diluted with the same volume of ultrapure water. After filtration on a 0.2 µm PTFE filter, the extract was analyzed by LC/ESI-MS/MS.
In vitro digestion assay: All the artificial digestive juices (saliva, gastric juice, duodenal juice and bile) were prepared according to the original protocol proposed by Versantvoort et al. (2005) [25] . The evaluation of the stability of ginger constituents under digestive conditions was performed as proposed by Falavigna et al. (2012) [26] with slight modifications. Very briefly, in vitro gastrointestinal digestion started by adding 150 µL of saliva to 140 mg of dry extract, obtained by evaporating 2 mL of the methanolic extract under a gentle stream of nitrogen. After an incubation period of 5 min at 37°C under stirring (250 rpm), the oral phase was stopped by the addition of 300 µL of gastric juice and the mixture was incubated again for 2 h. Finally, 600 µL of duodenal juice, 300 µL of bile and 100 µL of 1 M bicarbonate solution were added simultaneously to the mixture, and a final incubation step of 2 h was performed. At the end of the experiment, 1 mL of bidistilled water and 2 ml of methanol were added to the chime, the mixture was stirred for 5 min and then filtered through a 0. 
